Kintor Pharma prices IPO high to net $240m

pills adobe stock 575x375 pharmaceuticals
By Jonathan Breen
18 May 2020

Kintor Pharmaceutical has notched another success for the healthcare sector, raising HK$1.86bn ($240m) from its IPO after pricing the deal at the top of the marketed range.

The Mainland-based firm hit the market last week, following three other Chinese healthcare-related issuers that have listed in Hong Kong since March. The sector has been defiant through the coronavirus crisis, remaining one of the few popular sectors, running counter-cyclical to downward trending global financial markets.

Kintor Pharma kicked ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial